연구물
21건 검색
- 연구출판물 · 학술지 논문Afatinib 복약 후 발생한 비소세포성 폐암환자의 피부독성 부작용에 대한 한방치료 1례
Traditional Korean Medicine for Skin Toxic Side Effects from Afatinib in a Non-Small Cell Lung Cancer Patient: A Case Report
- 연구출판물 · 학술지 논문Afatinib 표적항암치료를 시행 중인 흉막 전이된 비소세포폐암 환자의 한방치료 증례보고
A Case Report of Korean Medicine Treatment of Non-small Cell Lung Cancer with Pleural Metastasis Following Targeted Chemotherapy with Afatinib
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer
Song, Si YeonPark, Ji Hye박소정Kang, In-CheolYoo, Hwa-Seung
- 연구출판물 · 학술지 논문JCR Q3Scopus Q1A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3First-line Afatinib in Patients with Non-small-cell Lung Cancer with Uncommon EGFR Mutations in South Korea
- 연구출판물 · 학술지 논문JCR Q1Scopus Q2KCI Q3Efficacy and safety of first-line afatinib in older patients with advanced EGFR-mutated non-small cell lung cancer
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
Choi, JuwhanChoi, Chang MinChang, Yoon SooLee, Kye YoungKim, Seung Joon윤성훈외 11명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q2Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
Lee, Sung YongChoi, Chang-MinChang, Yoon SooLee, Kye YoungKim, Seung Joon윤성훈외 11명
- 연구출판물 · 학술지 논문Scopus Q2KCI Q3Persistent Corneal Epithelial Defects Associated with Afatinib Therapy in a Patient with Non–Small Cell Lung Cancer: A Case Report
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG)
Popat, SanjayJung, Hyun AeLee, Shin YupHochmair, Maximilian J.Lee, Seung Hyeun이민기외 7명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1KCI Q1Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced-stage EGFR-mutated non-small-cell lung cancer
Kim, Taeyun이상진Jang, Tae-Won
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)
Halmos, BalazsTan, Eng-HuatSoo, Ross A.Cadranel, Jacques이민기외 9명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies
Miura, SatoruJung, Hyun AeLee, Shin YupLee, Seung Hyeun이민기외 6명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Model-Based Evaluation of HangAmDan-B1 and Afatinib Combination Therapy in HCC827 Xenograft Mice with Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Evaluate the Efficacy and Safety of HAD-B1 for Dose-Finding in EGFR Mutation Positive and Locally Advanced or Metastatic NSCLC Subjects Who Need Afatinib Therapy
Ko, Eun-JuKwag, Eun-BinPark, Ji HyePark, So-JungSon, Ji-Woong윤성훈외 2명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma
Oh, In-JaeHur, Jae YoungPark, Cheol-KyuKim, Young-ChulKim, Seung Joon이민기외 4명



로그인
홈
Researcher Page
ISNI
ORCID